Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis

Fig. 1

Course of DAS over time for the SDFR and non-SDFR group in the total RA population studied, and for ACPA-negative RA and ACPA-positive RA separately. Legend: Course of DAS over time of patients achieving sustained DMARD-free remission (SDFR) within 7 years of follow-up (n = 149), and those not (n = 623). In ACPA-positive patients, the line of the SDFR group was restricted to 5 years of follow-up because of insufficient data thereafter. Statistically significant differences in course of DAS over time, between the SDFR group and non-SDFR group, were indicated by with *. ACPA anti-citrullinated protein antibody, DAS disease activity scores, RA rheumatoid arthritis, SDFR sustained DMARD-free remission

Back to article page